The technique and recent experience incorporating cryosurgery into our community practice for primary treatment of @entity263 is described. Between December 2000 and December 2001, a total of 93 @entity1 underwent targeted cryoablation for @entity263 . Of the 93 @entity1 , 18 had failed radiotherapy, and cryotherapy was used as salvage therapy. The remaining 75 @entity1 underwent targeted cryoablation of the prostate as primary therapy. A single urologist using an argon-based cryoablation system performed the procedure. Cryoprobes and thermosensors were placed under transrectal ultrasound guidance via a transperineal route. A double freeze-thaw cycle was used with anterior-to- posterior probe operation. Strategically placed thermosensors were used to monitor and control the freezing, and a warming catheter was used to protect the urethra. We achieved a nadir @entity1486 level of < or =0.4 ng/mL in 84% of the entire population we studied (63 of 75 @entity1 ). Postsurgery complications were minimal. Incontinence developed in 4 @entity1 , as did postsuprapubic catheter removal urinary retention. @entity323 developed in 28 of 34 @entity1 who were potent preoperatively, with 6 of the 34 @entity1 regaining potency after surgery. No rectourethral @entity292 formation occurred. Urethral sloughing was observed in 5 @entity1 , 1 of whom developed a @entity733 during treatment of the sloughing. The use of cryoablation of the prostate for the treatment of localized @entity263 is feasible and can easily be transferred from the pioneering centers to the community hospitals without sacrificing safety or efficacy.

Cryosurgery as primary treatment for XXXX : a community hospital experience.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity323 :: ('MESH:D007172', 'Disease') :: ['Erectile dysfunction'] @entity263 :: ('MESH:D011471', 'Disease') :: ['adenocarcinoma of the prostate', 'localized prostate cancer'] @entity292 :: ('MESH:D005402', 'Disease') :: ['fistula'] @entity733 :: ('MESH:D000038', 'Disease') :: ['scrotal abscess'] @entity1486 :: ('354', 'Gene') :: ['prostate-specific antigen']
@entity263 :: (MESH:D011471,Disease) :: ['localized prostate cancer']
